Fluoroquinolones and valvulopathy

Are fluoroquinolones linked to an increased risk of aortic or mitral regurgitation? This possible association has been examined in a recently published pharmacoepidemiological study. Data from the FDA adverse reporting system database was used to analysed for a a...

Dietary supplements and breast cancer treatment outcomes

People undergoing treatment for various malignancies often use of dietary supplements during their therapy, perhaps without sufficient regard to the potential consequences. It is possible that some supplements (especially antioxidants), could compromise the...

Drug-related deaths in the USA

The nature of case-mix coding may well be impacting on the data used to estimate drug-related excess mortality in the USA. Using annual death rates for 1999–2016 stratified by state, sex, five-year age group, and cause of death, researchers have modelled the...

EHRs not a fail-safe to prevent medication errors

Electronic health records (EHR) are becoming increasingly common in health systems, and one of the purported advantages of implementation is protection from medication safety events, including medication errors. American researchers used data from a national,...